The Healthcare Professionals team at Clasado Biosciences will be attending the upcoming British Society of Lifestyle Medicine annual conference, BSLM 2022. 

Held 22-24 September at Tottenham Hotspur Stadium, London, the conference sees speakers from around the world share insight and perspective into all aspects of lifestyle medicine. The 2022 event is themed around community, including the various socio-economic factors impacting public health. 

Clasado will be represented at the event by its Healthcare Professionals team, which works with medical professionals, dietitians, nutritionists and learning institutions to communicate the benefits of prebiotics in terms of both proactive everyday wellbeing and targeted health applications. Throughout the event, the team will be sharing insight on the role of prebiotics and their potential within dietary strategies and health interventions. 

Dr Lucien Harthoorn, R&D Director at Clasado, said: “We are delighted to exhibit at the upcoming BSLM 2022 conference and once again connect directly with today’s healthcare professionals. With a three-day programme covering many key aspects of health, such as dietary behaviours, mental wellbeing and sleep health, there is a lot of opportunity to highlight the evolving role of prebiotics.”

Dr Harthoorn continues: “At the event, we’ll be educating visitors about the benefits of prebiotics, and showcasing Bimuno DAILY, our prebiotic supplement that nourishes bifidobacteria, a beneficial type of gut bacteria connected to supporting improved digestive health, immune function and mental wellbeing. As we discover more about our health in more connected terms, the evidence increasingly backs a well-supported gut microbiome as an essential building block for health and wellbeing.

“With gut health staying at the top of the agenda, the BSLM event is a fantastic opportunity for us to turn our expertise into actionable insights for healthcare professionals. By doing so, we’re playing our part in supporting better public health through a better-supported gut microbiome.”

Clasado is the developer of the most studied prebiotic galactooligosaccharide (GOS) ingredient, Bimuno® GOS. Backed by over 100 scientific publications and more than 20 clinical trials, the ingredient is the most studied of its kind available on the market.

The ingredient is used in the company’s multi award-winning finished dietary supplement, Bimuno® DAILY, and is available to brands and formulators for use in their own new product development. 

To learn more about the event, please visit https://bslm.org.uk/events/bslm2022/

To find out more about the HCP engagement platform at Clasado, please visit https://www.bimuno.com/professionals.list